The estimated Net Worth of Onaiza Cadoret Manier is at least $1.69 Milione dollars as of 1 February 2024. Ms. Manier owns over 2,125 units of Ionis Pharmaceuticals Inc stock worth over $1,523,637 and over the last 5 years she sold IONS stock worth over $164,398. In addition, she makes $0 as Chief Corporate Development and Commercial Officer at Ionis Pharmaceuticals Inc.
Onaiza has made over 8 trades of the Ionis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 2,125 units of IONS stock worth $105,400 on 1 February 2024.
The largest trade she's ever made was exercising 15,062 units of Ionis Pharmaceuticals Inc stock on 16 January 2024 worth over $640,587. On average, Onaiza trades about 2,076 units every 41 days since 2020. As of 1 February 2024 she still owns at least 35,825 units of Ionis Pharmaceuticals Inc stock.
You can see the complete history of Ms. Manier stock trades at the bottom of the page.
Onaiza Cadoret-Manier serves as Chief Corporate Development and Commercial Officer of the Company. Prior to joining Ionis, from 2018 to 2019 Ms. Cadoret-Manier was the chief commercial officer for Grail Biosciences, an early detection genomics company. Prior to Grail, Ms. Cadoret-Manier was vice president of the Respiratory Franchise at Genentech where she worked from 2011 to 2018. Ms. Cadoret-Manier also has held multiple senior management positions overseeing corporate strategy, alliances, and marketing and sales for numerous disease areas for Genentech, Pfizer and Amylin Pharmaceuticals.
Onaiza Manier is 56, she's been the Chief Corporate Development and Commercial Officer of Ionis Pharmaceuticals Inc since 2020. There are 22 older and 4 younger executives at Ionis Pharmaceuticals Inc. The oldest executive at Ionis Pharmaceuticals Inc is Breaux Castleman, 79, who is the Independent Director.
Onaiza's mailing address filed with the SEC is C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM, MA, 02451.
Over the last 9 years, insiders at Ionis Pharmaceuticals Inc have traded over $32,069,332 worth of Ionis Pharmaceuticals Inc stock. The most active insiders traders include Stanley T Crooke, B Lynne Parshall e Michael R Hayden. On average, Ionis Pharmaceuticals Inc executives and independent directors trade stock every 8 days with the average trade being worth of $445,289. The most recent stock trade was executed by Richard S Geary on 28 August 2024, trading 651 units of IONS stock currently worth $32,159.
ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.
Ionis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: